Aneuxal en es it fr

Aneuxal Brand names, Aneuxal Analogs

Aneuxal Brand Names Mixture

  • No information avaliable

Aneuxal Chemical_Formula


Aneuxal RX_link

No information avaliable

Aneuxal fda sheet

Aneuxal msds (material safety sheet)

Aneuxal Synthesis Reference

No information avaliable

Aneuxal Molecular Weight

309.469 g/mol

Aneuxal Melting Point

< 25 oC

Aneuxal H2O Solubility

Soluble as HCl salt

Aneuxal State


Aneuxal LogP


Aneuxal Dosage Forms

Tablets (oral, 1 mg)

Aneuxal Indication

Used for the symptomatic treatment of parkinsonism.

Aneuxal Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Aneuxal Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Aneuxal side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Aneuxal Patient Information

Aneuxal Organisms Affected

Humans and other mammals